Taizhou Mabtech Pharmaceutical Co.,ltd

This early-stage study tests a new injectable drug called CMAB015, which is similar to the approved psoriasis treatment Cosentyx. It involves 114 healthy Chinese men to compare how the body processes the drug, its safety, and whether it triggers an immune response. The goal is to…

This study tests a new medication (omalizumab α) against the approved drug Xolair for people with long-term hives that don't get better with antihistamines. About 392 adults aged 15 to 75 took part. The main goal was to see how well the new drug reduces itching over 12 weeks.

This study checks if a manufacturing change to the drug EnliTuo® affects how it works in the body. About 86 healthy men aged 18-45 will receive a single dose and be monitored for safety, drug levels, and immune response. The goal is to ensure the updated version is similar to the…